Literature DB >> 22736792

No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.

Andrea N Burnett-Hartman1, Polly A Newcomb, Stephen M Schwartz, Roberd M Bostick, Michael Pawlita, Tim Waterboer, John D Potter.   

Abstract

BACKGROUND: Oncogenic human papillomaviruses (HPV) are sexually transmitted and linked to several epithelial malignancies, but an association between HPV and colorectal neoplasia is not established. Previously, we reported a three-fold increase in the odds of colorectal hyperplastic polyps associated with oncogenic HPV seropositivity in men but detected no HPV DNA in colorectal tissues from these same men.
METHODS: To test the reproducibility of our prior HPV antibody results and to explore the hypothesis that colorectal hyperplastic polyps may be associated with sexual behavior in men, we conducted a case-control study of hyperplastic polyps and antibodies to eight oncogenic HPV types (including 16 and 18), Herpes simplex virus-2 (HSV-2), and hepatitis C virus (HCV). Study participants were men, ages 30-74 years, enrolled in the Minnesota Cancer Prevention Research Unit Polyp Study who had an index colonoscopy from 1991 to 1994, and received a diagnosis of hyperplastic polyps (n = 97) or were polyp-free (n = 184). Plasma was assessed for antibodies to the eight oncogenic HPV types, HSV-2, and HCV using a bead-based multiplex assay.
RESULTS: The adjusted ORs for the association between hyperplastic polyps and seropositivity to oncogenic HPV (all eight types combined) was 0.84 [95% confidence interval (CI), 0.44-1.58; for HSV-2, OR, 0.98, 95% CI, 0.48-1.99; and for HCV, OR, 0.61; 95% CI, 0.11-3.26].
CONCLUSIONS: Our study suggested no association between colorectal hyperplastic polyps and antibodies to specific sexually transmitted infections (STI) in men. IMPACT: Factors associated with STIs are unlikely to play a role in the etiology of colorectal hyperplastic polyps in men. ©2012 AACR

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736792      PMCID: PMC3436996          DOI: 10.1158/1055-9965.EPI-12-0651

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus.

Authors:  Tim Waterboer; Bolormaa Dondog; Kristina M Michael; Angelika Michel; Markus Schmitt; Salvatore Vaccarella; Silvia Franceschi; Gary Clifford; Michael Pawlita
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

Review 2.  Human papillomavirus and cancer: the epidemiological evidence.

Authors:  N Muñoz
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

3.  No evidence for human papillomavirus in the etiology of colorectal polyps.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Denise A Galloway; Margaret M Madeleine; Michelle A Wurscher; Joseph J Carter; Karen W Makar; John D Potter; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-04       Impact factor: 4.254

4.  Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.

Authors:  Annika Antonsson; Adele C Green; Kylie-Ann Mallitt; Peter K O'Rourke; Michael Pawlita; Tim Waterboer; Rachel E Neale
Journal:  J Gen Virol       Date:  2010-03-10       Impact factor: 3.891

5.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

Authors:  Tim Waterboer; Peter Sehr; Kristina M Michael; Silvia Franceschi; John D Nieland; Thomas O Joos; Markus F Templin; Michael Pawlita
Journal:  Clin Chem       Date:  2005-08-11       Impact factor: 8.327

6.  Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study.

Authors:  J D Potter; R M Bostick; G A Grandits; L Fosdick; P Elmer; J Wood; P Grambsch; T A Louis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-10       Impact factor: 4.254

7.  InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.

Authors:  Freddy Sitas; Sam Egger; Margaret I Urban; Philip R Taylor; Christian C Abnet; Paolo Boffetta; Dianne L O'Connell; David C Whiteman; Paul Brennan; Reza Malekzadeh; Michael Pawlita; Sanford M Dawsey; Tim Waterboer
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

Review 8.  Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature.

Authors:  Laura Lorenzon; Mario Ferri; Emanuela Pilozzi; Maria Rosaria Torrisi; Vincenzo Ziparo; Deborah French
Journal:  Int J Colorectal Dis       Date:  2010-09-01       Impact factor: 2.571

  8 in total
  4 in total

1.  Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.

Authors:  Danny V Colombara; James P Hughes; Andrea N Burnett-Hartman; Stephen E Hawes; Denise A Galloway; Stephen M Schwartz; Roberd M Bostick; John D Potter; Lisa E Manhart
Journal:  J Immunol Methods       Date:  2015-06-11       Impact factor: 2.303

2.  Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study.

Authors:  Danny V Colombara; Lisa E Manhart; Joseph J Carter; Stephen E Hawes; Noel S Weiss; James P Hughes; Matt J Barnett; Gary E Goodman; Jennifer S Smith; You-Lin Qiao; Denise A Galloway
Journal:  Cancer Causes Control       Date:  2015-09-28       Impact factor: 2.506

3.  Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control study.

Authors:  Danny V Colombara; Lisa E Manhart; Joseph J Carter; Stephen E Hawes; Noel S Weiss; James P Hughes; You-Lin Qiao; Philip R Taylor; Jennifer S Smith; Denise A Galloway
Journal:  BMC Cancer       Date:  2016-06-01       Impact factor: 4.430

4.  Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.

Authors:  Nicole Brenner; Alexander J Mentzer; Julia Butt; Kathrin L Braband; Angelika Michel; Katie Jeffery; Paul Klenerman; Barbara Gärtner; Paul Schnitzler; Adrian Hill; Graham Taylor; Maria A Demontis; Edward Guy; Stephen J Hadfield; Rachael Almond; Naomi Allen; Michael Pawlita; Tim Waterboer
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.